Cox proportional hazard model for survival prediction of non-cancer end-stage liver disease.

Cox proportional hazard model for survival prediction of non-cancer end-stage liver disease.</p

Baseline demographic and laboratory characteristics of non-cancer cirrhotic patients in derivation and validation data sets.

Baseline demographic and laboratory characteristics of non-cancer cirrhotic patients in derivation and validation data sets.</p

Comparisons of ROC curves of the 3-month, 6-month and at the end of follow-up mortality prediction among the novel score, MELD score, and MELD-Na score in non-cancer related cirrhotic patients.

A. ROC curves of the 3-month mortality prediction among the three scores (n = 811). The AUC were 0.7873 (95% CI; 0.769–0.803), 0.7053 (95% CI; 0.684–0.727; P 0.001), 0.8038 (95% CI; 0.786–0.821; PB. ROC curves of the 6-month mortality prediction among the three scores (n = 887). The AUC were 0.7807 (95% CI; 0.763–0.799), 0.7023 (95% CI; 0.682–0.723; PPC. ROC curves of at the end of follow-up mortality prediction among the three scores (n = 1188). The AUC were 0.7713 (95% CI; 0.754–0.789), 0.6937 (95% CI; 0.674–0.714; P 0.001), 0.7852 (95% CI; 0.769–0.802; P = 0.0021) in MELD, MELD-Na, and the novel model, respectively.</p

Comparison of demographic and laboratory characteristics of all non-cancer cirrhotic patients with and without mortality during the follow-up period between 2010–2014.

(N = 4080).</p

Survival prediction among patients with non-cancer-related end-stage liver disease

BackgroundPredicting the survival of non-cancer related end-stage-liver-disease patients in general practice has been difficult for physicians because of the extremely variable trajectories due to multiple complex clinical factors, hence it remains a challenging issue to date. This study aimed to develop and validate a specific prognostic scoring system to early recognize the prognosis and improve the quality of end-of life care for non-cancer end-stage-liver-disease population.Materials and methodsA multicentre, retrospective cohort study was conducted during January 2010 ~ December 2012 and continued follow-up until December 2014. A cox proportional hazard regression analysis was used to derive and validate an optimized model. The main outcome measures were the 28-day, 3-month, 6-month, and 12-month mortality prediction. The performance of the novel model was evaluated, including discrimination and calibration.ResultsA total of 4,080 consecutive subjects were enrolled. The AUROCs for the 3-month survival discrimination in the MELD, MELD-Na and novel model were 0.787, 0.705 and 0.804 (PConclusionThis is a clinically relevant, validated scoring system that can be used sequentially to stratify the prognosis in non-cancer cirrhotic populations, which may help the patients along with medical team in decision making to improve the quality of end-of-life care.</div

Approximate quintile of modified-MELD score distribution of the predicted vs. observed survival cases in the derivation and validation sets.

Approximate quintile of modified-MELD score distribution of the predicted vs. observed survival cases in the derivation and validation sets.</p

Flow chart of patients included in the study (n = 4080).

Flow chart of patients included in the study (n = 4080).</p

Comparisons of discrimination ability among the novel score, the MELD and MELD-Na scores for non-cancer cirrhotic patients in the derivation data set.

Comparisons of discrimination ability among the novel score, the MELD and MELD-Na scores for non-cancer cirrhotic patients in the derivation data set.</p

Additional file 1: Figures S1-2 and Tables S1-2. of Excessive adiposity, metabolic health, and risks for genital human papillomavirus infection in adult women: a population-based cross-sectional study

(DOCX 671 kb

Histological examination.

<p>H&E staining of infected tissue was performed on days 2 (phase I), 5 (phase II) and 10 (phase III). Based on observations of the spleen, abscesses (indicated by arrows) occurred during phases I (A, 100×), II (B, 100×) and III (C, 100×). The lesions became very large during phase III (magnification, 10×; lower left corner of C). Based on observations of the liver, abscesses consisting of degraded neutrophils and cellular debris (indicated by white arrows) occurred during phases I (D, 100×), II (E, 100×) and III (F, 100×). Necrotic hepatocytes (indicated by gray arrows) were present in phase II and expanded during phase III. Normal hematogenous cells were observed in the BM during phase I (G, a representative femur image; 100×), and cellular debris (indicated by arrows) was present in the femur and vertebrae during phases II (H, a representative vertebral image; 100×) and III (I, a representative femur image; 100×). Because brain histological changes did not occur during phases I and II, only representative images of sections prepared during phase III are shown, including neutrophil (N) migration in cerebral margins (J, 400×), neutrophil infiltration in the meningeal subarachnoid space (K, 400×) and the accumulation of darkly stained cells (indicated by arrows) in the meninges (L, 100×). Using high magnification, both neutrophils (N) and lymphocytes (Ly) were observed (400×; upper right corner in L). Severe histopathological changes (indicated by arrows), including suppurative meningitis (M, 100×), cerebellar microabscess (N, 100×) and brain stem encephalitis (O, 100×), are indicated.</p